Perioperative diabetic and hyperglycemic management issues

Critical Care Medicine

Volumn 32, Issue 4 SUPPL., 2004, Pages

  Coursin, Douglas B ^a   Connery, Lisa E ^b   Ketzler, Jonathan T ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

Acute management; Acute myocardial infarction; Complications; Critical care; Critical illness; Diabetes mellitus; Hyperglycemia; Insulin; Length of hospital or intensive care unit stay; Outcome; Postcardiac surgery; Risk stratification; Stroke

Indexed keywords

CYTOKINE; GLUCOSE; HEMOGLOBIN A1C; HORMONE; INSULIN;

ACUTE HEART INFARCTION; CARDIOVASCULAR SURGERY; COMORBIDITY; CRITICAL ILLNESS; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HEART SURGERY; HUMAN; HYPERGLYCEMIA; INTENSIVE CARE; LENGTH OF STAY; MORBIDITY; MORTALITY; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; STROKE; TREATMENT OUTCOME;

EID: 1842789053     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ccm.0000115623.52021.c0     Document Type: Review

References (81)

1. Van den Berghe G, Wouters P, Weekers F, et al: Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345:1359-1367
2. Capes SE, Hunt D, Malmberg K, et al: Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: A systematic overview. Lancet 2000; 355:773-778
3. Wass CT, Lanier WL: Glucose modulation of ischemic brain injury: Review and clinical recommendations. Mayo Clin Proc 1996; 71: 801-812
4. McCowan KC, Malhoota A, Bistrian BR: Endocrine and metabolic dysfunction syndromes in the critically ill. Crit Care Clin 2001; 17:107-124
5. Mesotten D, Van den Berghe G: Clinical potential of insulin therapy in critically ill patients. Crit Care Med 2001; 29:1714-1719
6. Coursin DB, Murray MJ: How sweet is euglycemia in the critically ill? Mayo Clinic Proc, In Press
7. Krinsley JS: Hyperglycemia is strongly associated with increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proceed, In Press
8. Weir CJ, Murray GD, Dyker AG, et al: Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long-term follow up study. BMJ 1997; 314: 1303-1306
9. Bruno A, Levine SR, Frankel MR, et al: Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology 2002; 59:669-674
10. Capes SE, Hunt D, Malmberg K, et al: Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients. Stroke 2001; 32:2426-2432
11. Williams LS, Rotich J, Qi R, et al: Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke. Neurology 2002; 59:67-71
12. Coutinho M, Gerstein HC, Wang Y, et al: The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95, 783 individuals followed for 12.4 years. Diabetes Care 1999; 22:233-240
13. Furnary AP, Gao G, Grunkemeier GL, et al: Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 2003; 125:1007-1021
14. Furnary AP, Zerr KJ, Grunkemeier GL, et al: Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 1999; 67:352-362
15. Das UN: Is insulin an anti-inflammatory molecule? Nutrition 2001; 17:409-413
16. Das UN: Insulin and the critically ill. Crit Care 2002; 6:262-263
17. Van den Berghe G, Wouters PJ, Bouillon R, et al: Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Crit Care Med 2003; 31:359-366
18. Groeneveld ABJ, Beishuizen A, Visser FC: Insulin: A wonder drug in the critically ill? Crit Care 2002; 6:102-105
19. Hansen TK, Thiel S, Wouters PJ, et al: Intensive insulin therapy exerts anti-inflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab 2003; 88:1082-1088
20. Finney SJ, Zekvaeld C, Elia A, et al: Glucose control and mortality in critically ill patients. JAMA 2003; 290:2041-2047
21. Centers for Disease Control and Prevention (CDC): Prevalence of diabetes and impaired fasting glucose in adults - United States, 1999-2000. MMWR Morbid Mortal Wkly Rep 2003; 52:833-837
22. Weinstock RS: Treating type 2 diabetes mellitus: A growing epidemic. Mayo Clin Proc 2003; 78:411-413
23. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003; 26(Suppl 1):S5-S20
24. Arias E, Anderson RN, Kung H-C, et al: Deaths: Final data for 2003. National Vital Statistics Report 2003; 52:1-116
25. Gerich JE: Contributions of insulin-resistance and insulin-secretory defects to the pathogenesis of type 2 diabetes mellitus. Mayo Clin Proc 2003; 78:447-456
26. Boord JB, Graber AL, Christman JW, et al: Practical management of diabetes in critically ill patients. Am J Respir Crit Care Med 2001; 164:1763-1767
27. Magee MF, Bhatt BA: Management of decompensated diabetes - diabetic ketoacidosis and hyperglycemic hyperosmolar syndrome. Crit Care Clin 2001; 17:75-106
28. Narayan KM, Boyle JP, Thompson TJ, et al: Lifetime risk for diabetes mellitus in the United States. JAMA 2003; 290:1884-1890
29. Umpierrez GE, Isaacs SD, Bazargan N, et al: Hyperglycemia: An independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 2002; 87:978-982
30. Ketzler JT, Angelini GA, Coursin DB: Perioperative care of the diabetic. ASA Refresher Courses in Anesthesiology 2001; 29:1-9
31. Redberg RF, Greenland P, Fuster V, et al: Prevention conference VI: Diabetes and cardiovascular disease: Writing group III: Risk assessment in persons with diabetes. Circulation 2002; 105:144-152
32. Eagle KA, Berger PB, Calkins H, et al: ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery - executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation 2002; 105:1257-1267
33. O'Neill PA, Davies, Fullerton KJ, et al: Stress hormone and blood glucose response following acute stroke in the elderly. Stroke 1991; 22:842-847
34. Mizock BA: Alterations in carbohydrate metabolism during stress: A review of the literature. Am J Med 1995; 98:75-84
35. Dessai D, March R, Water JM: Hyperglycemia after trauma increases with age. J Trauma 1989; 29:719-723
36. Hotamisligil GS, Spiegelman BM: Tumor necrosis factor alpha: A key component of the obesity-diabetes link. Diabetes 1994; 43: 1271-1278
37. Stuart CA, Shangraw RE, Prince MJ, et al: Bed-rest induced insulin resistance occurs primarily in muscle. Metabolism 1988; 37: 802-806
38. Takala J, Ruokonen E, Webster NR, et al: Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 1999; 341:785-792
39. Grundy S, Benjamin I, Burke G, et al: Diabetes and cardiovascular disease: A statement for healthcare professionals from the American Heart Association. Circulation 1999; 100:1134-1146
40. Melamed E: Reactive hyperglycaemia in patients with acute stroke. J Neurol Sci 1976; 29:267-275
41. Anderson RE, Tan WK, Martin HS, et al: Effects of glucose and Pa02 modulation on cortical intracellular acidosis, NADH redox state, and infarction in the ischemic penumbra. Stroke 1999; 30:160-170
42. De Crespigny AJ, Rother J, Beaullieu C, et al: Rapid monitoring of diffusion DC potential, and blood oxygenation changes during global ischemia: Effects of hypoglycemia, hyperglycemia, and TTX. Stroke 1999; 30:2212-2222
43. Tracey BA, Parsons MW, Phanh G, et al: Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke 2003; 34:2208-2214
44. Scott JF, Robinson GM, French JM, et al: Glucose potassium insulin infusions in the treatment of acute stroke patients with mild to moderate hyperglycemia: The glucose insulin in stroke trial (GIST). Stroke 1999; 30:793-799
45. Demchuk AM, Morgenstern LB, Krieger DW, et al: Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke. Stroke 1999; 30:34-39
46. Bonow RO, Mitch WE, Nesto RW, et al: Prevention conference VI diabetes and cardiovascular disease writing group V: Management of cardiovascular-renal complications. Circulation 2002; 105:e159-e164
47. Schrier RW, Estacio RO: Additional follow-up from the ABCD Trial in patients with type 2 diabetes and hypertension. N Engl J Med 2000; 343:1969
48. UK Prospective Diabetes Study Group: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317: 703-13
49. Chobanian AV, Bakris GL, Black HR, et al: The Seventh Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: The JNC 7 Report. JAMA 2003; 289: 2560-2571
50. Estacio RO, Jeffers BW, Hiatt WR, et al: The effect of nisoldopine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension. N Engl J Med 1998; 338:645-652
51. Staessen JA, Wang JG, Thijs L: Calcium-channel blockade and cardiovascular prognosis: Recent evidence from clinical outcome trials. Am J Hypertension 2002; 15:85S-93S
52. Oswald GA, Smith CC, Betteridge DJ, et al: Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction. BMJ 1986; 293: 917-922
53. Bolk J, van der Ploeg T, Cornel JH, et al: Impaired glucose metabolism predicts mortality after a myocardial infarction. Int J Cardiol 2001; 79:207-214
54. Malmberg K, Norhammar A, Wedel H, et al: Glycometabolic state at admission: Important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: Long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 1999; 99: 2626-2632
55. Gerstein HC, Pais P, Pogue J, et al: Relationship of glucose and insulin levels to the risk of myocardial infarction: A case-control study. J Am Coll Cardiol 1999; 33:612-619
56. Jesson ME: Glucose control during cardiac surgery: How sweet it is. J Thorac Cardiovascular Surg 2003; 125:985-987
57. Jonassen AK, Sack MN, Mjos AD, et al: Protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling. Circ Res 2001; 89:1191-1198
58. McNulty PH: Comparison of local and systemic effects of insulin on myocardial glucose extraction in ischemic heart disease. Am J Physiol Heart Circ Physiol 2000; 278: 1208-1212
59. Ritz E, Orth SR: Nephropathy in patients with type 2 diabetes mellitus. N Engl J Med 1999; 341:1127-1133
60. Gaede P, Vedel P, Larsen N, et al: Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003; 348:383-393
61. Mangano CM, Diamondstone LS, Ramsay JG, et al: Renal dysfunction after myocardial revascularization: Risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group. Ann Inter Med 1998; 128: 194-203
62. Lovati E, Richard A, Frey BM, et al: Genetic polymorphisms of the renin-angiotensin-aldosterone system in end-stage renal disease. Kidney Int 2001; 60:46-54
63. Chew ST, Newman MF, White WD, et al: Preliminary report of the association of apolipoprotein E polymorphisms with postoperative peak serum creatinine concentrations in cardiac surgical patients. Anesthesiology 2000; 93:325-331
64. Hogan KJ: Genomics in perioperative care. In: Critical Care Medicine-Perioperative Management. Second Edition. Murray MJ, Coursin DB, Pearl RG, et al (Eds). Philadelphia, Lippincott, Williams & Wilkins, 2002, pp 63-69
65. Chantrel F, Enache I, Bouiller M, et al: Abysmal prognosis of patients with type 2 diabetes entering diabetes. Nephrol Dial Transplant 1999; 14:129-136
66. Corwin HL, Gettinger A, Pearl RG, et al: Efficacy of recombinant human erythropoietin in critically ill patients: A randomized trial. JAMA 2002; 288:2827-2835
67. Mancini DM, Kaz SD, Lang CC: Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure. Circulation 2003; 107:294-299
68. Provenzano R, Lorber D, MaClellan W: Prevalence of anemia in diabetic patients with chronic kidney disease and treatment with epoetin. Am J Kidney Dis 2002; 39:A26
69. Yusuf S, Sleight P, Pogue J, et al: Effects of angiotensin-converting- enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. N Engl J Med 2000; 342:145-153
70. Ritz E: Albuminuria and vascular damage-the vicious twins. N Engl J Med 2003; 348: 2349-2352
71. Lee HT, Sladen RN: Perioperative Renal Protection. In: Critical Care Medicine - Perioperative Management. Murray MJ, Coursin DB, Pearl RG, et al (Eds). Second Edition. Philadelphia, Lippincott, Williams & Wilkins, 2002, pp 503-520
72. Tepel M, van Der Giet M, Schwarzfeld C, et al: Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 2000; 343: 180-184
73. Marenzi G, Marana I, Lauri G, et al: The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. N Engl J Med 2003; 349:1333-1340
74. Koch J-A, Plum J, Grabensee B, et al: Prostaglandin E1: A new agent for the prevention of renal dysfunction in high risk patients caused by radiocontrast media? Nephrol Dial Transplant 2000; 15:43-49
75. Pflueger A, Larson TS, Nath KA et al: Role of adenosine in contrast media-induced acute renal failure in diabetes mellitus. Mayo Clin Proceed 2000; 75:1275-1283
76. Kermani A, Garg A: Thiazolidonedione-associated congestive heart failure and pulmonary edema. Mayo Clinic Proceed 2003; 78:1088-1091
77. Hogan KJ, Rusy DA, Springman SR: Difficult laryngoscopy and diabetes mellitus. Anesth Analg 1988; 67:1162-1165
78. Stein PK, Schmieg RE Jr, El-Foudy A, et al: Association between heart rate variability recorded on post operative day 1 and length of stay in abdominal aortic surgery patients. Crit Care Med 2001; 29:1738-1743
79. Gu W, Pagel PS, Warltier DC, et al: Modifying cardiovascular risk in diabetes mellitus. Anesthesiology 2003; 98:774-779
80. Available online at: http://content.nejm.org/ cgi/content/full/346/20/ 1586/DCl. Accessed October 25, 2003
81. Annane D, Melchior JC: Hormone replacement therapy for the critically ill. Crit Care Med 2003; 31:634-635